Disnea y calidad de vida en la enfermedad pulmonar obstructiva crónica

Archivos de Bronconeumologia

Volumn 38, Issue 10, 2002, Pages 485-488

  Sanjuas C ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; DRUG DERIVATIVE; IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL; SALMETEROL; SCOPOLAMINE DERIVATIVE; TIOTROPIUM;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DYSPNEA; EMOTION; EXERCISE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; INTERVIEW; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; TIME;

ALBUTEROL; BRONCHODILATOR AGENTS; CLINICAL TRIALS; DYSPNEA; EMOTIONS; EXERCISE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; INTERVIEWS; IPRATROPIUM; MULTIVARIATE ANALYSIS; PLACEBOS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SCOPOLAMINE DERIVATIVES; TIME FACTORS;

EID: 0346044538     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(02)75270-8     Document Type: Review

References (32)

1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
2. Marín JM. Manifestaciones clínicas: la disnea y su importancia en el paciente con EPOC. Arch Bronconeumol 2001;37(Supl 1):8-13.
3. Marín JM, Carrizo SJ, Gascón M, Sánchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1395-9.
4. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:967-75.
5. Debigaré R, Côté CH, Maltais F. Peripheral muscle wasting in Chronic Obstructive Pulmonary Disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 2001;164:1712-7.
6. American Thoracic Society. Dyspnea: mechanisms, assessment and management: a consensus statement. Am J Respir Crit Care Med 1999;159:321-10.
7. McCathie HCF, Spence SH, Tate RL. Adjustement to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J 2002;19:47-53.
8. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001;56:880-7.
9. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-7.
10. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999;116:1632-7.
11. Ferrer M, Alonso J. Medición de la calidad de vida en los pacientes con EPOC. Arch Bronconeumol 2001;37(Supl 2):20-6.
12. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
13. Güell R, Casan P, Sangenís M, Morante F, Belda J, Guyatt GH. Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire. Eur Respir J 1998;11:55-60.
14. Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, et al. Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996;9:1160-6.
15. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997;127:1072-9.
16. Williams JEA, Singh SJ, Sewell L, Guyatt GH, Morgan MDL. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax 2001;56:954-9.
17. Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, et al. Interpretation of quality of life scores from the St. George's Respiratory Questionnaire. Eur Respir J 2002;19:405-13.
18. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NMB, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax 1997;52:879-87.
19. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:785-90.
20. Rutten-van Mölken M, Roos B, Van Noord JA. An empirical comparison of the St. George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999;54:995-1003.
21. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187-92.
22. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
23. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19:398-404.
24. Hajiro T, Nishimura K. Minimal clinically significant difference in health status: the thorny path of health status measures? [editorial]. Eur Respir J 2002;19:390-1.
25. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155: 1283-9.
26. Dahl R, Greefhorst LAPM, Nowak D, Nonikov V, Byrne AM, Thomson MH, et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:778-84.
27. Vincken W, Van Noord JA, Greefhorst APM, Bantje TA, Kesten S, Korducki L, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002;19:209-16.
28. Casaburi R, Mahler DA, Jones PW, Wanner A, San Pedro G, Zu-Wallack RL, et al. A long term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19:217-24.
29. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115-9.
30. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results of a year of outpatient mullidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-8.
31. Güell R, Casan P, Belda J, Sangenís M, Morante F, Guyatt GH, et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000;117:976-83.
32. Leyenson V, Furukawa S, Kuzma AM, Cordova F, Travaline J, Criner GJ. Correlation of changes in quality of life after lung volume reduction surgery with changes in lung function, exercise, and gas exchange. Chest 2000;118:728-35